Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-06

FDA Approved: AZELAIC ACID — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for azelaic acid by Actavis Pharma, expanding/updating its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azelaic acid (azelaic acid)

Snippet

SUPPL AP for AZELAIC ACID (AZELAIC ACID)